Johnny Kao
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer (NCT00970502) | Johnny Kao | 2007-02-01 |
| Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer (NCT00462735) | Johnny Kao | 2007-02-01 |
Track Johnny Kao automatically
Every clearance here is in the API, with alerts when new ones post.